Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury

Tatyana Verina1, Ali Fatemi, Michael V Johnston

  • 1Neurology and Developmental Medicine, Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, Maryland 21205, USA.

Pediatric Neurology
|April 16, 2013
PubMed

Insights

Umbilical cord blood stem cells show promise for treating brain injuries in newborns. These cells offer neuroregeneration potential, targeting multiple injury aspects for improved outcomes in developing brains.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Neonatal Neurology

Background:

  • Perinatal hypoxic-ischemic brain injury and stroke are significant causes of long-term neurological disability in developing brains.
  • Emerging research indicates that stem cell transplantation, specifically from human umbilical cord blood, may offer therapeutic benefits.

Purpose of the Study:

  • To explore the therapeutic potential of umbilical cord blood stem cells for neuroregeneration and functional recovery following perinatal brain injury.
  • To investigate the capacity of these stem cells to target multiple neuropathologic events and their suitability for transplantation.

Main Methods:

  • Review of preclinical studies on stem cell transplantation in various brain injury models, with a focus on immature animal models.
  • Analysis of factors influencing transplanted cell survival, migration, and function, including recipient age and sex.

Main Results:

  • Human umbilical cord blood stem cells possess pluripotent capacity, enabling simultaneous targeting of multiple injury pathways.
  • Transplanted cell survival, migration, and function are influenced by recipient biological characteristics.
  • Preclinical data support ongoing clinical safety trials in neonates.

Conclusions:

  • Umbilical cord blood stem cells present a promising therapeutic option for perinatal brain injuries due to their regenerative potential and immunologic properties.
  • Further research is essential to optimize transplantation protocols and fully elucidate the mechanisms underlying their efficacy.
  • Findings from preclinical studies are guiding current clinical investigations in neonates.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.